Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-07-05
2011-07-05
Sheikh, Humera (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S451000, C424S452000, C424S456000, C424S465000
Reexamination Certificate
active
07972621
ABSTRACT:
The invention disclosed herein relates to a pharmaceutical composition comprising a carrier and an active ingredient, wherein the carrier is at least one fish gelatin predetermined on the basis of the molecular weight profile of the gelatin. In some embodiments, particularly when the concentration of carrier comprises a relatively lower percentage of the total composition, the carrier may be exclusively a high molecular weight fish gelatin, or may be comprised of a mixture with standard molecular weight gelatin in which high molecular weight gelatin comprises a predominant portion. In those embodiments where the concentration of carrier comprises a relatively larger percentage of the total composition, the carrier may be an exclusively standard molecular weight fish gelatin, or may be comprised of a mixture in which standard molecular weight gelatin comprises a predominant portion. Thus, compositions may be designed to optimize performance for various required gelatin concentration formulations.
REFERENCES:
patent: 4760093 (1988-07-01), Blank et al.
patent: 4760094 (1988-07-01), Blank et al.
patent: 4767789 (1988-08-01), Blank et al.
patent: 5039540 (1991-08-01), Ecanow
patent: 5079018 (1992-01-01), Ecanow
patent: 5330763 (1994-07-01), Gole et al.
patent: 6110486 (2000-08-01), Dugger, III
patent: 6258380 (2001-07-01), Overholt
patent: 6284270 (2001-09-01), Lagoviyer et al.
patent: 6465010 (2002-10-01), Lagoviyer et al.
patent: 6709669 (2004-03-01), Murray et al.
patent: 6726928 (2004-04-01), Yarwood et al.
patent: 2004/0076666 (2004-04-01), Green et al.
patent: 2004/0138098 (2004-07-01), Fein
patent: 2005/0232997 (2005-10-01), Nilsson et al.
patent: 2006/0134194 (2006-06-01), Banbury et al.
patent: 2008/0274951 (2008-11-01), Fein
patent: 2009/0005432 (2009-01-01), Fein
patent: 2009/0318665 (2009-12-01), Nilsson et al.
patent: 2010/0056436 (2010-03-01), Fein
patent: 1 367 066 (2003-12-01), None
patent: 1548022 (1979-07-01), None
patent: 2111423 (1983-06-01), None
patent: 145783 (2006-10-01), None
patent: WO94/11438 (1994-05-01), None
patent: WO94/14422 (1994-07-01), None
patent: 00/61117 (2000-10-01), None
patent: 01/10418 (2001-02-01), None
patent: 2004/041153 (2004-05-01), None
patent: 2004/043439 (2004-05-01), None
EP Pharmacopoeia 4thed. Section 2.6.12 (Microbial Examination of Non-Sterile Products (Total Viable Aerobic Count)].
Supplementary European Search Report dated Feb. 7, 2011 issued in European Appln. No. 05758824.6.
Brzozowski Andrzej Jan
Grother Leon Paul
Wong Desmond Yik Teng
Fitzpatrick ,Cella, Harper & Scinto
R.P. Scherer Technologies, LLC
Sheikh Humera
LandOfFree
Process for formulating fast dispersing dosage forms... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for formulating fast dispersing dosage forms..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for formulating fast dispersing dosage forms... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643294